Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmatory Study of Dotinurad for Hyperuricemia
NCT02416167Phase 2Completed
- Sponsor
- Fuji Yakuhin
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dotinurad in hyperuricemia, gout, sponsored by Fuji Yakuhin. Started May 2015; status: completed.
02
Drugs
dotinurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on NCT02416167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02416167.